Xinhao Xu
Overview
Explore the profile of Xinhao Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang J, Guo X, Bao A, Ma Y, Wang Y, Xu X, et al.
ACS Appl Mater Interfaces
. 2025 Feb;
17(10):15675-15687.
PMID: 40017099
β-GaO, as a semiconductor material with an ultrawide band gap ( > 4.8 eV), emerges as a promising candidate for ultraviolet (UV)-transparent semiconductors. Its distinctive property of high transparency from...
2.
Zhan R, Liu Y, Wu J, Shen Y, Xu X, Lin G, et al.
Drug Des Devel Ther
. 2025 Jan;
19():219-228.
PMID: 39830785
Background: Givinostat, a potent histone deacetylase (HDAC) inhibitor, is promising for the treatment of relapsed leukemia and myeloma. Purpose: This study aimed to develop and verify a quick assay for...
3.
Yu L, Chen Z, Wu W, Xu X, Lv Y, Li C
Nutrients
. 2024 Dec;
16(23).
PMID: 39683610
An increasing number of studies have explored the effects of precooling on endurance exercise performance in the heat, yet the available results remain inconsistent. Therefore, this study aimed to investigate...
4.
Xu X, Wang Y, Xu Y, Tan F
Chemosphere
. 2024 Nov;
368:143743.
PMID: 39547290
We investigated the contaminations of phthalates (PAEs), organophosphate esters (OPEs), and polycyclic aromatic hydrocarbons (PAHs) in the vegetables and their corresponding soils from 26 plastic greenhouses of Northeast China. PAEs,...
5.
Chen Z, Chen C, Liu Y, Xu X, Luo S
BMC Chem
. 2024 Nov;
18(1):215.
PMID: 39497182
We established a method based on ultra performance liquid chromatography tandem mass spectrometry (UPLC‒MS/MS) to quantitatively measure tepotinib, which was validated as acceptable and used in the evaluation of food-drug...
6.
Xia H, Xu X, Chen J, Wu H, Shen Y, Chen X, et al.
Front Pharmacol
. 2024 Oct;
15:1495855.
PMID: 39399470
[This corrects the article DOI: 10.3389/fphar.2024.1403649.].
7.
Xia H, Xu X, Chen J, Wu H, Shen Y, Chen X, et al.
Front Pharmacol
. 2024 Sep;
15:1403649.
PMID: 39329117
Ivacaftor is the first potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR) protein approved for use alone in the treatment of cystic fibrosis (CF). Ivacaftor is primarily metabolized by...
8.
Hu J, Xia H, Chen X, Xu X, Wu H, Shen Y, et al.
BMC Cancer
. 2024 Sep;
24(1):1131.
PMID: 39261851
Background: Sunitinib, a newly developed multi-targeted tyrosine kinase inhibitor (TKI), has become a common therapeutic option for managing advanced renal cell carcinoma (RCC). Examining the mechanism underlying the interaction between...
9.
Yu W, Cui B, Han J, Zhu S, Xu X, Tan J, et al.
Adv Sci (Weinh)
. 2024 Jul;
11(36):e2405135.
PMID: 39049722
Lithium-ion batteries with transition metal sulfides (TMSs) anodes promise a high capacity, abundant resources, and environmental friendliness, yet they suffer from fast degradation and low Coulombic efficiency. Here, a heterostructured...
10.
Xia H, Wu H, Chen J, Xu X, Tan W, Xu R
Chem Biol Interact
. 2024 Jul;
399:111131.
PMID: 38964639
Dabrafenib is a BRAF inhibitor that has been demonstrated to be efficacious in the treatment of melanoma and non-small-cell lung cancer patients with BRAF V600E mutations. The objective of this...